Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

282.72
+3.121.12%
Post-market: 282.720.00000.00%19:26 EDT
Volume:303.69K
Turnover:85.97M
Market Cap:6.28B
PE:-15.74
High:287.27
Open:281.03
Low:275.00
Close:279.60
Loading ...
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 20, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]